Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan
Journal of Atherosclerosis and Thrombosis · 2024
DOI: 10.5551/jat.64223 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2024. Verfasst von Kazunori Toyoda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center. Hauptthemen laut MEDLINE: Hemostatics, Thrombosis, Pyridines, Thiazoles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center.
- Department of Neurology, Steel Memorial Yawata Hospital.
- National Hospital Organization Sendai Medical Center.
- Department of Neurology, National Hospital Organization Nagoya Medical Center.
- Yokosuka Kyosai Hospital.
- Department of Neurosurgery, Japanese Red Cross Kumamoto Hospital.
Zitieren
APA
Toyoda, K., Arakawa, S., Ezura, M., Kobayashi, R., Tanaka, Y., Hasegawa, S., Yamashiro, S., Komatsu, Y., Terasawa, Y., Masuno, T., Kobayashi, H., Oikawa, S., & Yasaka, M. (2024). Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64223
Vancouver
Toyoda K, Arakawa S, Ezura M, Kobayashi R, Tanaka Y, Hasegawa S, et al. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan. Journal of Atherosclerosis and Thrombosis. 2024. doi:10.5551/jat.64223
BibTeX
@article{Toyoda2024,
author = {Toyoda, Kazunori and Arakawa, Shuji and Ezura, Masayuki and Kobayashi, Rei and Tanaka, Yoshihide and Hasegawa, Shu and Yamashiro, Shigeo and Komatsu, Yoji and Terasawa, Yuka and Masuno, Tomohiko and Kobayashi, Hiroshi and Oikawa, Suzuko and Yasaka, Masahiro},
title = {Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2024},
doi = {10.5551/jat.64223}
}
EUVIMED